D-0099-2023 Class II Terminated

Recalled by Nephron Sterile Compounding Center LLC — West Columbia, SC

FDA drug recall D-0099-2023 was initiated by Nephron Sterile Compounding Center LLC on Jan 6, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Sep 24, 2024). Affected quantity: 38,830 syringes.

Recall details

Product Type
Drugs
Report Date
Jan 18, 2023
Initiation Date
Jan 6, 2023
Termination Date
Sep 24, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
38,830 syringes

Product description

Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-924-05

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the USA.

Code information

Lot: RC2011A, Exp. 2/22/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0099-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0099-2023. Report a data issue: hello@regdatalab.com.